Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Epidemiology and Management of Insomnia in Children with Autistic Spectrum Disorders

Miano, Silvia, Ferri, Raffaele · 2010 · Pediatric Drugs

Abstract

Insomnia is the predominant sleep concern in children with autistic spectrum disorder (ASD), and its nature is most likely multifactorial, with neurochemical (abnormalities in serotonergic transmission or melatonin levels), psychiatric (anxiety), and behavioral (poor sleep habits) etiological factors involved. Children with ASD experience sleep problems similar to those of typically developing children, although the prevalence is markedly higher, occurring in 44-83% of school-aged children with ASD. Caregivers usually report that insomnia is the most frequent sleep disorder, described as disorders of initiating and maintaining sleep, restless sleep, bedtime resistance, co-sleeping, alterations of sleep hygiene, and early awakenings in the morning. Many actigraphic studies have added information on sleep disorders, confirming the questionnaire findings in the majority of cases. There are relatively few polysomnographic data for ASD, compared with questionnaire studies, and most of these studies reported a reduction in total sleep time and more undifferentiated sleep in the youngest patients. These findings were associated with several sleep microstructure alterations during rapid eye movement (REM) sleep, and with non-REM (NREM) sleep microstructure changes that appeared to be related to cognitive impairment rather than to the autistic core. Moreover, few data about other less frequent sleep disorders, such as periodic limb movements disorder and obstructive sleep apnea syndrome, bruxism, and the influence of epilepsy and EEG abnormalities, are available. Both pharmacologic and behavioral interventions have been suggested for the treatment of sleep problems in autistic children. The most common types of behavioral interventions are complete extinction (removing reinforcement to reduce a behavior) and various forms of graduated extinction. Melatonin has shown promising results in the treatment of insomnia in children with ASD. Although controlled studies are limited, there are more data demonstrating the safety and effectiveness of melatonin in ASD than for other sedative/hypnotic drugs. Finally, a dual treatment for insomnia in ASDs with melatonin and behavioral techniques has been suggested. A recent study using a combination of genetic and functional experimental techniques reported evidence that low melatonin concentration caused by a primary deficit in acetylserotonin methyltransferase activity is a risk factor for ASD. Sleep problems usually start at the same age as developmental regression, suggesting a higher vulnerability at this period of life. Further studies, beginning at younger ages, are necessary to better investigate these aspects and the role of melatonin in insomnia in children with ASD.

Overview

Integrity signals

Registry

Crossref · 10.2165/11316140-000000000-00000

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 83 references

Research works printed but not linked: 7

  1. Hoshino, 1984, Folia Psychiatr Neurol Jpn, 38, 45
  2. Wiggs, 1996, J Intellect Disabil Res, 40, 518, 10.1111/j.1365-2788.1996.tb00662.x · doi:10.1111/j.1365-2788.1996.tb00662.x · Paper page
  3. Segawa, 1992, Brain Dev, 14, S46
  4. Elia, 1995, Am J Ment Retard, 100, 6
  5. Ballaban-Gil, 2000, Ment Retard Dev Disabil Res Rev, 6, 300, 10.1002/1098-2779(2000)6:4<300::AID-MRDD9>3.0.CO;2-R · DOI · Paper page
  6. Mindell, 2006, Sleep, 29, 1263
  7. Ishizaki, 1999, No To Hattatsu, 31, 428

Cited by

See all 80

Metadata

Authors
Miano, S., & Ferri, R.
Affiliations
  • Azienda Ospedaliera Sant'Andrea (IT)
  • Oasi Maria SS (IT)
Corresponding author
Miano, Silvia
Venue
Pediatric Drugs
Published
2010-04
Volume
12
Issue
2
Pages
75-84
ISSN
1174-5878 (ISSN-L)
OpenAlex
W2063425373
Cited by
80
References
83
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 13 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 8
FWCI
0.88
Type
journal article
Language
en
Open access
closed
Locations
  • Pediatric Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
insomnia, autism spectrum disorder, children, sleep disorders, melatonin, behavioral interventions, extinction, sleep hygiene, NREM sleep, developmental regression, sleep apnea, bruxism, epilepsy, anxiety, bedtime resistance, actigraphy, polysomnography
MeSH terms
Age Factors, Autistic Disorder, Behavior Therapy, Child, Electroencephalography, Epilepsy, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Melatonin, Surveys and Questionnaires, Polysomnography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology and Management of Insomnia in Children with Autistic Spectrum Disorders. https://app.cochat.ai/papers/10.2165/11316140-000000000-00000
The paper
Miano, S., & Ferri, R. (2010). Epidemiology and Management of Insomnia in Children with Autistic Spectrum Disorders. Pediatric Drugs. https://doi.org/10.2165/11316140-000000000-00000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.